Tuesday, 17 June 2014
Acute heart failure–the rapid onset of symptoms and signs secondary to abnormal cardiac function–may occur as new-onset symptoms in a patient without previous known cardiac dysfunction or as acute decompensation of chronic heart failure. Both presentations are often life-threatening and require urgent treatment. Acute heart failure was therefore the ideal focus for the recent annual meeting of the British Society for Heart Failure, which took place in London in November 2013.
Wednesday, 14 May 2014
Homozygous familial hypercholesterolaemia (FH) is a rare disorder with a very high risk of premature cardiac death that must be diagnosed and treated from childhood onwards, usually with lifelong lipoprotein apheresis. Heterozygous FH is much commoner, with a high risk of cardiovascular disease in adults that can be prevented by early diagnosis and statin therapy. HEART UK - The Cholesterol Charity - has provided editorial support and review of this sponsored FH series.This article was made possible by an unrestricted educational grant by Sanofi, who had no control over content.
Friday, 28 February 2014
Remote monitoring is an emerging model of care in heart failure (HF) which has been shown to be clinically beneficial. In this study, patients were recruited to a new telemonitoring programme after referral to a community HF service. Following enrolment, there was a 58% reduction in the risk of HF admissions (0.71 vs. 0.30 per year, p
Monday, 10 February 2014
There have been significant advances in the management of coronary artery disease (CHD) in recent years; including in medical therapy, revascularisation, secondary prevention, cardiac rehabilitation and lifestyle interventions, which have resulted in improved prognosis and life expectancy. As a consequence, an increasing number of patients are living longer with CHD, the commonest clinical presentation of which is angina pectoris. In patients with stable angina, the focus of treatment has therefore shifted towards ensuring optimal symptom control and improving quality of life. Ranolazine is an antianginal approved for patients with stable angina, whose symptoms are inadequately controlled by - or they are intolerant of - first-line therapy.
Thursday, 19 December 2013
Dr David Milne GPwSI in Cardiology
Thursday, 12 September 2013
It has become increasingly clear that many people in this country are putting themselves at risk because they are continuing to drink above their recommended weekly units. Most of these people are not drunk drivers in police cells or antisocial drinkers arriving at A&E departments on Saturday night. They are people who come to see us at our chronic disease clinics or for treatment for an acute illness. The inclusion of questions about alcohol in NHS Health Checks is the ideal opportunity to discuss the potential risks of excessive drinking, and this special issue explains how we can help patients to choose a healthier approach to alcohol.
Thursday, 12 September 2013
We are a nation with an alcohol-induced dichotomy: we have a love affair with alcohol but are increasingly aware of its dangers. The pub has been a cornerstone of our society, providing a source of relationships and artistic imagination. However, our nation's favourite drug is also responsible for as many life-years lost as tobacco, but with additional psychological and socio-economic costs.